Shire to acquire specialty drugmaker NPS Pharmaceuticals for $5.2 Billion
Shire now wants to pursue its goal to become a biotech powerhouse through acquisitions. Irish drugmaker Shire PLC announced Sunday it has agreed to pay $5.2bn (£3.4bn, €4.4bn) i
